Training

 In an industry that’s rapidly diversifying and innovating it’s important to know that you can continue to upgrade your skills.Training is something we do extremely well and an area we continue to put many of our resources towards.

Through an industry led steering committee, LSAM offers a variety of courses and training resources so that companies can effectively train their employees to meet their current and future needs while individuals can enrich their career paths, learn new skills and offer more knowledge back to their employers.

Our training commitment to you:

• To develop and provide educational and professional opportunities to our member companies;
• To research and identify training needs in the industry;
• To identify opportunities for training partnerships.

Training Rebate Information Sheet

Training Rebate Application

Training Rebate Questionnaire

We select training opportunities based on surveys of the entire industry. We consult with members to ensure all of our courses meet rigorous industry standards. Where it doesn’t exist, we create training courses and where there are exceptional opportunities, we highlight them for you. All LSAM members and their employees receive discounts on registrations.

• Lean Office - One day workshop

  Want to further your knowledge applying core lean tools?

  12-01-2012 Read More

• Sterile Product Assurance - Building a Tangible Case for the Sterility Assurance of Your Parenteral Product & FDA, EU, ICH Expectations and Recommendations

  Presented By: Peter Calcott Ph. D. This live, interactive webinar is provided by the Tungsten Shield Group. Most biological, biotechnological and many pharmaceutical s are administered parenterally and therefore must be produced sterile. Since many of these products are heat labile, including biologicals and biotechnology products, they can not be terminally sterilized in their final container but are rather aseptically processed.

  18-01-2012 Read More

• Combination Products – A New FDA Paradigm; FDA's New Proposal to Codify the cGMP Requirements Applicable to Combination Products

  Presented By: Barry A. Friedman Ph. D. This live, interactive webinar provided by the Tungsten Shield Group. Historically, the absence of clear cGMP requirements for Combination Products has resulted in inconsistent application as to the applicable agency center to submit product for review. Products for both CDER and CBER as the primary Agency contact point may have historically been submitted to the incorrect organization for review because of a lack of knowledge as to the Primary Mode of Action (PMOA) of the product.

  24-01-2012 Read More

• Microbiological Issues in Non-Sterile Manufacturing & The Regulatory Expectations

  Non-sterile manufacturing involves issues and challenges many times overlooked in aseptic operations. These include the handling and evaluating of non-sterile components, environments and products. This live, interactive webinar provided by the Tungsten Shield Group.

  25-01-2012 Read More

• The USP <62> Microbiological Examination of Non-Sterile Products: Tests for Specified Microorganisms

  Presented By: Barry A. Friedman Ph. D. This live, interactive webinar is provided by the Tungsten Shield Group. In May 2009 the United States Pharmacopeia (USP), revision 32, implemented the long awaited separation of USP General Chapter <61> Microbial Limit Tests into two new chapters, i.e., USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration, and USP <62> Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms.

  31-01-2012 Read More